Clinical trial
Evaluation of the Efficacy and Safety of Peramivir in Subjects With…
NCT00419263 · BioCryst Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00419263 |
|---|---|
| Title | Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza. |
| Official title | A Phase II, Multicenter, Randomized, Double-Mask, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza. |
| Lead sponsor | BioCryst Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Drug |
| Interventions | Peramivir 150 mg, Peramivir 300 mg, Placebo |
| Enrollment | 344 |
| Start date | Jan 1, 2007 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Jan 8, 2007 |
| Last update posted | Feb 12, 2015 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: